NeuroMetrix reports Quell Technology to be used in NIH-Funded trial evaluating effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmatic clinical trial of TENS for fibromyalgia. Fibromyalgia is